WallStreetZenWallStreetZen

NASDAQ: LYEL
Lyell Immunopharma Inc Stock Ownership - Who owns Lyell Immunopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lyell Immunopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Innovative Cellular Therapeutics Holdings Ltd10% Owner2026-07-1710$13.70
$137.00Sell
Cellular Therapeuti Innovative10% Owner2026-07-1710$13.70
$137.00Sell
Innovative Cellular Therapeutics Holdings Ltd10% Owner2026-07-1610$13.73
$137.30Sell
David ShookChief Medical Officer2026-06-101,977$12.64
$24.99kSell
Lynn SeelyPresident and CEO2026-05-11388$18.91
$7.34kSell
Gary K. LeeChief Scientific Officer2026-05-11130$18.92
$2.46kSell
Veronica Sanchez BulisVP Corporate Controller2026-05-11217$18.91
$4.10kSell
Stephen J. HillChief Operating Officer2026-05-1189$18.92
$1.68kSell
Arch Venture Fund XIII LP10% Owner2026-03-06488,090$25.61
$12.50MBuy
Arch Venture Partners IX LLC10% Owner2026-03-06488,090$25.61
$12.50MBuy

1 of 4

LYEL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LYEL insiders and whales buy or sell their stock.

LYEL Shareholders

What type of owners hold Lyell Immunopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Nelsen234.07%54,619,074$803.45MInsider
Arch Venture Partners IX LLC167.75%39,143,667$575.80MInsider
Glaxosmithkline PLC129.65%30,253,189$445.02MInsider
Richard Klausner24.18%5,641,764$82.99MInsider
Hans Edgar Bishop20.08%4,685,614$68.93MInsider
Arch Venture Management LLC13.92%3,247,162$47.77MInstitution
Cellular Therapeuti Innovative12.25%2,857,480$42.03MInsider
Innovative Cellular Therapeutics Holdings Ltd12.25%2,857,480$42.03MInsider
Cellular Therapeutics Holding Innovative11.89%2,774,980$40.82MInsider
Arch Venture Fund XIII LP7.92%1,848,755$27.20MInsider

1 of 3

LYEL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYEL8.02%91.98%Net BuyingNet Selling
FHTX75.69%14.46%
FATE51.89%48.11%Net BuyingNet Selling
IKT80.07%19.93%Net BuyingNet Buying
IPSC76.61%23.39%Net SellingNet Selling
View Top Biotech Stocks

Lyell Immunopharma Stock Ownership FAQ

Who owns Lyell Immunopharma?

Lyell Immunopharma (NASDAQ: LYEL) is owned by 54.28% institutional shareholders, 622.63% Lyell Immunopharma insiders, and 0.00% retail investors. Robert Nelsen is the largest individual Lyell Immunopharma shareholder, owning 54.62M shares representing 234.07% of the company. Robert Nelsen's Lyell Immunopharma shares are currently valued at $803.45M.

If you're new to stock investing, here's how to buy Lyell Immunopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.